
Protalix BioTherapeutics PLX
€ 2.23
-6.69%
Land |
|
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NYSE AMERICAN |
Anteile |
78.5 M |
Marktkapitalisierung |
$ 197 M |
EBITDA (LTM) |
$ -4.04 M |
P/E (LTM) |
-33.375 |
P/S (LTM) |
3.976157 |
EPS (LTM) |
-0.08 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
NovaBay Pharmaceuticals
NBY
|
- | - | $ 11.3 M | NYSE American | ||
|
NeuroBo Pharmaceuticals
NRBO
|
- | 0.43 % | $ 12 M | Nasdaq Global Select Market | ||
|
OncoCyte Corporation
OCX
|
- | 17.22 % | $ 355 K | NYSE American | ||
|
Onconova Therapeutics
ONTX
|
- | -0.47 % | $ 21 M | Nasdaq Capital Market | ||
|
Opthea Limited
OPT
|
- | - | $ 1.2 B | Nasdaq Global Select Market | ||
|
Verastem
VSTM
|
$ 9.38 | -4.82 % | $ 650 M | Nasdaq Global Market | ||
|
BiomX
PHGE
|
$ 1.85 | 14.2 % | $ 3.02 M | NYSE American | ||
|
Pieris Pharmaceuticals
PIRS
|
- | -15.58 % | $ 1.22 B | Nasdaq Capital Market | ||
|
Plus Therapeutics
PSTV
|
- | - | $ 301 M | Nasdaq Capital Market | ||
|
Pluristem Therapeutics
PSTI
|
- | -1.9 % | $ 33.3 M | Nasdaq Global Select Market | ||
|
Qualigen Therapeutics
QLGN
|
- | 5.59 % | $ 1.16 M | Nasdaq Global Select Market | ||
|
Qilian International Holding Group Limited
QLI
|
- | -6.08 % | $ 184 M | Nasdaq Global Select Market | ||
|
Cassava Sciences
SAVA
|
- | - | $ 110 M | Nasdaq Capital Market,SPB | ||
|
Selecta Biosciences
SELB
|
- | -8.69 % | $ 126 M | Nasdaq Global Market | ||
|
Sangamo Therapeutics
SGMO
|
- | - | $ 50.4 M | Nasdaq Global Select Market | ||
|
Salarius Pharmaceuticals
SLRX
|
- | - | $ 2.64 M | Nasdaq Global Select Market | ||
|
Sensei Biotherapeutics
SNSE
|
- | - | $ 17.5 M | Nasdaq Global Market | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
- | - | $ 826 K | Nasdaq Global Select Market | ||
|
Synthetic Biologics
SYN
|
- | 1.32 % | $ 16.2 M | NYSE American | ||
|
Synlogic
SYBX
|
- | - | $ 7.07 M | Nasdaq Global Market | ||
|
Virios Therapeutics, LLC
VIRI
|
- | 2710.01 % | $ 72.9 M | Nasdaq Capital Market | ||
|
Vallon Pharmaceuticals
VLON
|
- | -6.47 % | $ 5.76 M | Nasdaq Global Select Market | ||
|
Vaxart
VXRT
|
- | -25.06 % | $ 46.3 M | Nasdaq Capital Market,SPB | ||
|
XOMA Corporation
XOMA
|
- | - | $ 485 M | Nasdaq Global Select Market | ||
|
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market | ||
|
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market | ||
|
Windtree Therapeutics
WINT
|
- | - | $ 26.8 M | Nasdaq Global Select Market | ||
|
Trean Insurance Group
TIG
|
- | - | $ 316 M | Nasdaq Global Select Market | ||
|
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | ||
|
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | ||
|
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | ||
|
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX | ||
|
ММЦБ
GEMA
|
- | - | - | MOEX | ||
|
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | ||
|
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | ||
|
Промомед
PRMD
|
- | - | - | MOEX | ||
|
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | ||
|
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | ||
|
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | ||
|
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | ||
|
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | ||
|
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market | ||
|
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | ||
|
Annexon
ANNX
|
$ 4.0 | -7.62 % | $ 620 M | Nasdaq Global Select Market | ||
|
Alnylam Pharmaceuticals
ALNY
|
$ 156.5 | -2.85 % | $ 20.5 B | Nasdaq Global Select Market,SPB | ||
|
Amgen
AMGN
|
$ 462.71 | -3.3 % | $ 249 B | Nasdaq Global Select Market,SPB | ||
|
Theratechnologies
THTX
|
- | - | $ 83.9 M | Nasdaq Capital Market | ||
|
Iovance Biotherapeutics
IOVA
|
$ 7.72 | -11.26 % | $ 2.76 M | Nasdaq Global Market,SPB | ||
|
Biogen
BIIB
|
$ 243.85 | -4.17 % | $ 35.7 B | Nasdaq Global Select Market,SPB | ||
|
Ironwood Pharmaceuticals
IRWD
|
$ 4.03 | 6.9 % | $ 652 M | Nasdaq Global Select Market |